Cancer Genetics, Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House
Published on: Friday, September 29th, 2017 View all Media
RUTHERFORD, N.J., September 29, 2017– Cancer Genetics, Inc. (Nasdaq: CGIX, the Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced it will be presenting at this year’s MicroCap Conference on October 5th in New York City.
Panna Sharma, CEO and President of CGI, will provide an overview of the Company’s business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.
6th Annual MicroCap Conference – Cancer Genetics, Inc. Presentation
Date: Thursday, October 5, 2017
Time: 11:00 am Eastern Time
Location: The Essex House in New York City
ABOUT CANCER GENETICS
Cancer Genetics, Inc. is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, Australia and China. We have established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.
The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State.